Oncotelic Therapeutics, Inc. (OTLC)
OTCMKTS · Delayed Price · Currency is USD
0.0513
-0.0032 (-5.79%)
Aug 1, 2025, 2:59 PM EDT

Oncotelic Therapeutics Company Description

Oncotelic Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of drugs for the treatment of orphan oncology indications.

It develops antisense and small molecule injectable drugs for the treatment of cancer. The company is also developing OXi4503 for the treatment of acute myeloid leukemia and myelodysplastic syndromes; OT-101, an antisense against TGF-β2, which is in phase 3 clinical trials for pancreatic cancer and glioblastoma, as well as for the treatment of various viruses, including severe acute respiratory syndrome and coronavirus.

In addition, it develops CA4P for the treatment of advanced metastatic melanoma; AL-101, an intranasal drug and delivery system for intra-nasal apomorphine for the treatment of parkinson’s disease, erectile disfunction, and female sexual disfunction; Artemisinin, a natural derivative from an Asian herb Artemisia Annua; and AI based technologies to enhance the development and commercialization of support technologies, as well as nanoparticle products for the treatments of various cancers.

The company is headquartered in Agoura Hills, California.

Oncotelic Therapeutics, Inc.
CountryUnited States
IndustryBiotechnology
SectorHealthcare
Employees26
CEOVuong Trieu

Contact Details

Address:
29397 Agoura Road
Agoura Hills, Delaware 91301
United States
Phone650 635 7000
Websiteoncotelic.com

Stock Details

Ticker SymbolOTLC
ExchangeOTCMKTS
Stock TypeCommon Stock
Fiscal YearJanuary - December
Reporting CurrencyUSD
ISIN NumberUS6283411097
SIC Code2836

Key Executives

NamePosition
Dr. Vuong Trieu Ph.D.Chairman and Chief Executive Officer
Amit ShahChief Financial Officer
Dr. Anthony E. Maida III, B.A., MA, MBA, Ph.D.Chief Medical Officer ? Translation Medicine and Director
Saranjit SaundCBO and GM of AI Division
Steven W. KingConsultant and Director
Dr. Larn HwangChief Scientific Officer
Dr. Seymour Howard Fein M.D.Chief Regulatory Officer and Chief Medical Officer
Burcak BeserChief Technology Officer of AI Division